Video

Baseball Hall of Famer Mike Schmidt promotes sun protection, skin cancer awareness

September 28, 2017
Mike Schmidt, a Major League Baseball Hall of Famer who played 17 seasons with the Philadelphia Phillies, received a stage III melanoma diagnosis in…

Video

Baseball Hall of Famer: Physician’s confidence affects patients

September 26, 2017
Mike Schmidt, whose success during his 17-year career with the Philadelphia Phillies earned him induction into the National Baseball Hall of Fame…

Video

Baseball star who survived melanoma ‘suffering’ from lack of sunscreen use

September 22, 2017
Mike Schmidt, a former member of the Philadelphia Phillies widely considered to be the greatest third baseman in Major League Baseball history…

In the Journals

Rule of three may be more effective than rule of two in melanoma testing

September 21, 2017
Compared with the rule of two for detecting melanoma, the rule of three was more effective in identifying genetic risk factors for the disease in a…

Mike Schmidt, baseball great and melanoma survivor, promotes importance of ‘cancer game plan’

September 21, 2017
Mike Schmidt is widely considered the greatest third baseman in Major League Baseball history. His 548 career home runs rank 16th all time. The other…

Video

Baseball Hall of Famer Mike Schmidt ‘paying it forward’ through campaign to support patients with cancer

September 21, 2017
Mike Schmidt always felt a sense of invincibility as a professional athlete. That changed in 2013, when Schmidt — a member of the National…

In the Journals

Delayed Mohs surgery does not impact complication risk

September 15, 2017
The timing of Mohs micrographic reconstructive surgery had no impact on infection risk or flap failure, according to recent findings. The researchers…

Novel AI imaging approach yields improved skin cancer diagnosis

September 13, 2017
A novel imaging approach using artificial intelligence was associated with improved detection of parameters associated with melanoma, according to…

FDA News

FDA accepts application for binimetinib-encorafenib combination for BRAF-mutated melanoma

September 13, 2017
The FDA accepted for review new drug applications that seek the use of the COMBO450 regimen to treat patients with BRAF-mutant advanced…

Meeting News

Adjuvant vemurafenib confers clinical benefit in resected BRAF V600-positive melanoma

September 11, 2017
MADRID — Adjuvant vemurafenib conferred substantial clinical benefit to patients with completely resected stage IIC to stage IIIB BRAF

Meeting News

Dabrafenib-trametinib combination doubles RFS in resected stage III melanoma

September 11, 2017
MADRID — Adjuvant treatment with dabrafenib and trametinib doubled RFS compared with placebo among patients with resected stage III…

Meeting NewsPerspective

Nivolumab superior to ipilimumab for adjuvant treatment of surgically resected melanoma

September 11, 2017
MADRID — Adjuvant treatment with nivolumab significantly prolonged RFS compared with standard ipilimumab for patients with surgically resected…

FDA News

FDA grants breakthrough therapy designation to cemiplimab for advanced cutaneous squamous cell carcinoma

September 8, 2017
The FDA granted breakthrough therapy designation to cemiplimab for the treatment of adults with metastatic or locally advanced and unresectable…

In the Journals

Study identifies SNP, demographic factors associated with nonmelanoma skin cancer

September 1, 2017
The BsmI single-nucleotide polymorphism, along with several demographic factors, predicted nonmelanoma skin cancer risk, according to recent…

FDA News

FDA grants fast track designation to LN-144 for advanced melanoma

September 1, 2017
The FDA granted fast track designation to LN-144 for the treatment of advanced melanoma, according to the drug’s manufacturer. LN-144 (Iovance…

In the Journals

One-third of melanomas develop from preexisting nevus

August 30, 2017
Nevus-associated melanomas accounted for approximately one-third of all melanomas found in a recent systematic review and meta-analysis. Researchers…

FDA News

FDA grants breakthrough therapy designation to mogamulizumab for mycosis fungoides, Sézary syndrome

August 25, 2017
The FDA granted breakthrough therapy designation to mogamulizumab for the treatment of mycosis fungoides and Sézary syndrome, according to the…

In the Journals

BAP1 mutations may be associated with melanocytic tumors

August 25, 2017
Germline mutations in the BAP1 gene may be associated with melanocytic BAP1–mutated atypical intradermal tumors, according to recent findings…

In the Journals

Voriconazole may increase squamous cell carcinoma risk in hematopoietic transplant setting

August 21, 2017
Voriconazole was associated with a statistically significant increase in cutaneous squamous cell carcinoma risk in a cohort of individuals who…

In the Journals

Melanoma immunotherapy trials may not capture all toxicity data

August 17, 2017
Common Terminology Criteria for Adverse Events may not appropriately reflect immune-related adverse event severity, duration or timing, according to…

Healio Jobs